[ad_1] As a board-certified music therapist, Brian Harris knows firsthand the power of music to…
Biogen Inc.
-
-
STOCK MARKET
Biogen and Eisai release new Alzheimer’s drug data that may support wider uptake
by userby user[ad_1] Biogen Inc. and Eisai Co. late Wednesday released new data on their Alzheimer’s treatment…
-
STOCK MARKET
Quest Diagnostics launches first at-home blood test to assess risk of developing Alzheimer’s disease
by userby user[ad_1] Quest Diagnostics Inc. said Monday the first blood-based biomarker test to assess the risk…
-
[ad_1] Biogen Inc. BIIB, -4.23% said Tuesday that it will eliminate about 1,000 jobs as…
-
STOCK MARKET
FDA approves Alzheimer’s treatment Leqembi, clearing the way for Medicare coverage
by userby user[ad_1] The U.S. Food and Drug Administration on Thursday granted full approval to the Biogen…
-
STOCK MARKET
FDA advisers vote in favor of Biogen and Eisai’s collaborative Alzheimer’s treatment
by userby user[ad_1] Advisers to the U.S. Food and Drug Administration on Friday voted unanimously in favor…
-
STOCK MARKET
Eli Lilly stock jumps 8% after Alzheimer’s treatment slows disease progression in major trial
by userby user[ad_1] Eli Lilly & Co.’s stock jumped 8% premarket Wednesday, after the company LLY announced…
-
STOCK MARKET
Here’s how one hedge fund is going aginst the grain and beating the markets
by userby user[ad_1] White shoe Boston fund managers GMO — founded by Jeremy Grantham — is shooting…
-
STOCK MARKET
5 things to know about the new Alzheimer’s drug — including why it may be risky for people who take blood thinners
by userby user[ad_1] Shares of Eisai and Biogen did not move dramatically after the drug companies reported…
-
[ad_1] U.S. stocks were trading near unchanged Wednesday as traders looked ahead to a speech…
- 1
- 2